[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

This is a must read. --------------------------------------------------------------- [Potential Gold Rush For Investors Sparked By USA Vs. China Trade War](=) [And Create A Potential Boom For Investors](=) --------------------------------------------------------------- August 12, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Stop Buying Stocks... Until You Read This]() Rare market events have just created a huge opportunity for investors. A free report, prepared for you, details everything you'll want to know. [Get this report here.]() --------------------------------------------------------------- [Heron Therapeutics, HRTX](=) Recent Analyst Action: Boris Peaker, analyst at Cowen & Co., reiterates coverage on [Heron Therapeutics (HRTX)](=)in the Healthcare sector with a Buy rating and a price target of $5.5 (3 days ago). - Recent Price: $5.155 - Average Analyst Price Target: $7.75 (50.34%) - Market Cap: $499.08M [TipRanks.com]() also reports that [Heron Therapeutics](=)currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.75. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $5.50. [Heron Therapeutics (HRTX)](=)’s last closing price was $5.155 which would put the average price target at $7.75. Here are 3rd party ratings for [HRTX](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Buy, Top 37% (92 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [5X Potential Growth By 2030? Is This Little-Known Market About To Explode?](=) =It's used for our BELOVED Air Force's fighter jets, cell phones, and wind turbines. And soon, you're going to hear about it everywhere... because according to renowned intelligence reports... [Demand Will EASILY 5X By 2030! (Discover It HERE!)](=) = --------------------------------------------------------------- [Luminar Technologies, LAZR](=) Recent Analyst Action: Jaime Perez, analyst at R.F. Lafferty, reiterates coverage on [Luminar Technologies (LAZR)](=)in the Industrial Goods sector with a Buy rating and a price target of $24 (2 days ago). - Recent Price: $10.82 - Average Analyst Price Target: $14.78 (36.60%) - Market Cap: $3.52B [TipRanks.com]() also reports that [Luminar Technologies]()currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $14.78. The target pricing ranges from a high forecast of $24.00 down to a low forecast of $8.00. [Luminar Technologies (LAZR)]()’s last closing price was $10.82 which would put the average price target at $14.78. Here are 3rd party ratings for [LAZR](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 42% (145 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- [RumbleON, RMBL]( Recent Analyst Action: Eric Wold, analyst at B.Riley Financial, reiterates coverage on [RumbleON (RMBL)](=)in the Technology sector with a Buy rating and a price target of $38 (2 days ago). - Recent Price: $26.5 - Average Analyst Price Target: $34.00 (28.30%) - Market Cap: $435.05M [TipRanks.com]( also reports that [RumbleON](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $34.00. The target pricing ranges from a high forecast of $38.00 down to a low forecast of $30.00. [RumbleON (RMBL)](’s last closing price was $26.5 which would put the average price target at $34.00. Here are 3rd party ratings for [RMBL](): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Neutral Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Top 40% (100 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Is President Biden Finished Because of THIS?]() Polling shows the Biden administration is in big trouble. But what’s the REAL reason why Biden could resign in the next 30 days? According to Andrew Zatlin, a Bloomberg #1 ranked economist, the one issue which could trigger Biden’s resignation is surprising: It will likely NOT be related to inflation, rising gas prices, or cognitive health problems… [Go Here Now to Find Out The Surprising “Why” Biden Could Be Finished, How this New Crisis Could Play out With Disastrous Consequences for America…](=) [click]() --------------------------------------------------------------- [Phathom Pharmaceuticals, PHAT](=) Recent Analyst Action: Paul Choi, analyst at Goldman Sachs, reiterates coverage on [Phathom Pharmaceuticals (PHAT)](=)in the Healthcare sector with a Hold rating and a price target of $9 (1 week ago). - Recent Price: $9.92 - Average Analyst Price Target: $30.67 (209.17%) - Market Cap: $358.06M [TipRanks.com]( also reports that [Phathom Pharmaceuticals](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $30.67. The target pricing ranges from a high forecast of $45.00 down to a low forecast of $9.00. [Phathom Pharmaceuticals (PHAT)](’s last closing price was $9.92 which would put the average price target at $30.67. Here are 3rd party ratings for [PHAT](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Edgio, EGIO](=) Recent Analyst Action: Michael Elias, analyst at Cowen & Co., reiterates coverage on [Edgio (EGIO)](=)in the Technology sector with a Buy rating and a price target of $5.5 (1 month ago). - Recent Price: $3.735 - Average Analyst Price Target: $5.50 (47.26%) - Market Cap: $784.04M [TipRanks.com]( also reports that [Edgio](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.50. The target pricing ranges from a high forecast of $5.50 down to a low forecast of $5.50. [Edgio (EGIO)](=)’s last closing price was $3.735 which would put the average price target at $5.50. Here are 3rd party ratings for [EGIO](=): - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 46% (136 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [The Best $1 Investment You Can Make Today](=) =$1 doesn’t go very far these days... but now you can get stock recommendations from 5 investing titans [for just $1!](=) = --------------------------------------------------------------- [Lemonade, LMND]( Recent Analyst Action: Jason Helfstein, analyst at Oppenheimer, reiterates coverage on [Lemonade (LMND)](in the Financial sector with a Buy rating and a price target of $35 (2 days ago). - Recent Price: $32.7 - Average Analyst Price Target: $26.25 (-19.72%) - Market Cap: $2.10B [TipRanks.com](=) also reports that [Lemonade](currently has 6 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $26.25. The target pricing ranges from a high forecast of $40.00 down to a low forecast of $14.00. [Lemonade (LMND)](’s last closing price was $32.7 which would put the average price target at $26.25. Here are 3rd party ratings for [LMND](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Buy, Top 29% (74 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [AbSci, ABSI](=) Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on [AbSci (ABSI)](=)in the Services sector with a Buy rating and a price target of $10 (15 hours ago). - Recent Price: $4.93 - Average Analyst Price Target: $14.00 (194.12%) - Market Cap: $444.76M [TipRanks.com](=) also reports that [AbSci](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $14.00. The target pricing ranges from a high forecast of $28.00 down to a low forecast of $8.00. [AbSci (ABSI)](’s last closing price was $4.93 which would put the average price target at $14.50. Here are 3rd party ratings for [ABSI](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: Hold, Top 31% (79 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [Could Biden's Executive Order 14017 Trigger A BULL RUN For This Little-Known Industry?]() =You've never heard of this rare metal. But it's CRITICAL for our fighter jets, missiles, and military vehicles. The bad news is, Communist China has a MONOPOLY on this critical resource... [But Trump AND Biden's Executive Orders Could Change That, And Trigger A Boom For Investors]() --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, Editor, MarketSectorDaily.com [Unsubscribe](=) Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954